Treat ghosts who lure men to their demise as a guide, and not a villain
By Aparna S June 19, 2025: In the 1990s, no vacation was considered complete without the obligatory ghost story session. Every cousin, uncle,.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
By Aparna S June 19, 2025: In the 1990s, no vacation was considered complete without the obligatory ghost story session. Every cousin, uncle,.
HQ Team June 10, 2025: Mpox cases continue to surge and meet the criteria of a public health emergency of international concern, the.
HQ Team June 9, 2025: Canadian researchers have discovered a new candidate to fight drug-resistant bacteria, about three decades after the last antibiotic.
HQ Team June 5, 2025: Paradromics Inc., a US-based neurotechnology company, has completed its first-in-human surgical placement of its brain-computer interface. The safe.
HQ Team May 31, 2025: Autism and Parkinson’s disease share underlying biological mechanisms, and people with an autism diagnosis are four times more.
HQ Team May 29, 2025: Swiss-American Alcon Inc.’s acoltremon ophthalmic solution, Tryptyr, has received a green signal from the US Food and Drug.
By Aparna S. May 28, 2025: World Schizophrenia Day was observed recently to encourage society and mental health professionals to re-evaluate how we.
HQ Team May 24, 2025: The Food and Drug Administration has cleared GSK Plc’s drug for treating patients with inadequately controlled chronic obstructive.
HQ Team May 24, 2025: A federal judge has issued a temporary restraining order preventing the US administration from revoking Harvard’s ability to.
HQ Team May 20, 2025: Regeneron Pharmaceuticals, Inc. plans to buy most of the assets of the bankrupt genetics and biotechnology company, 23andMe.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com